- Home
- GDV vs VCYT Comparison
GDV vs VCYT Comparison
Compare GDV & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GDV | VCYT |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | GDV | VCYT |
|---|---|---|
| Price | $27.61 | $41.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $45.38 |
| AVG Volume (30 Days) | 186.0K | ★ 764.8K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 5.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $495,141,000.00 |
| Revenue This Year | N/A | $16.16 |
| Revenue Next Year | N/A | $10.92 |
| P/E Ratio | ★ N/A | $110.67 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $18.04 | $22.61 |
| 52 Week High | $23.00 | $50.71 |
Technical Indicators
Market Signals| Indicator | GDV | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 46.07 |
| Support Level | $27.06 | $41.90 |
| Resistance Level | $27.93 | $43.05 |
| Average True Range (ATR) | 0.21 | 1.21 |
| MACD | 0.03 | -0.30 |
| Stochastic Oscillator | 68.83 | 28.94 |
Price Performance
Historical ComparisonAbout GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.